Inventor
LAZAR GREGORY A
US18 patents
⚠️ This page may combine multiple inventors who share the name “LAZAR GREGORY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
8 patentsUS9605061B2Mar 28, 2017
Antibodies with modified isoelectric points
XENCOR INC43 citations98
US8362210B2Jan 29, 2013
Antibody variants with enhanced complement activity
XENCOR INC47 citations98
US10155800B2Dec 18, 2018
CTLA4-Ig immunoadhesins
XENCOR INC7 citations84
US9475881B2Oct 25, 2016
Antibody variants with enhanced complement activity
XENCOR INC7 citations84
US9371397B2Jun 21, 2016
CTLA4-Ig immunoadhesins
XENCOR INC7 citations84
US11352412B2Jun 7, 2022
CTLA4-IG immunoadhesins
XENCOR INC2 citations73
US11254727B2Feb 22, 2022
CTLA4-Ig immunoadhesins
XENCOR INC2 citations73
US12486311B2Dec 2, 2025
CTLA4-Ig immunoadhesins
XENCOR INC0 citations62
GENENTECH INC
5 patentsUS9708406B2Jul 18, 2017
Anti-transferrin receptor antibodies and methods of use
GENENTECH INC87 citations97
US10808036B2Oct 20, 2020
Anti-transferrin receptor antibodies and methods of use
GENENTECH INC5 citations83
US10508151B2Dec 17, 2019
Anti-transferrin receptor antibodies and methods of use
GENENTECH INC7 citations83
US11008403B2May 18, 2021
Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
GENENTECH INC3 citations71
US11098129B2Aug 24, 2021
Anti-transferrin receptor antibodies and methods of use
GENENTECH INC0 citations61
LAZAR GREGORY A
4 patentsUS8329867B2Dec 11, 2012
CTLA4-Ig immunoadhesins
LAZAR GREGORY A106 citations98
US8101720B2Jan 24, 2012
Immunoglobulin insertions, deletions and substitutions
LAZAR GREGORY A174 citations98
US9493578B2Nov 15, 2016
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
LAZAR GREGORY A28 citations93
US8629113B2Jan 14, 2014
CTLA4-Ig immunoadhesins
LAZAR GREGORY A24 citations92